QTRX
Quanterix CorpNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$164.29M
P/E Ratio
—
EPS
$-2.51
Beta
1.32
52W High
$8.77
52W Low
$3.36
50-Day MA
$5.36
200-Day MA
$5.78
Dividend Yield
—
Profit Margin
-77.10%
Forward P/E
—
PEG Ratio
—
About Quanterix Corp
Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advance precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the regions from Asia Pacific. The company is headquartered in Billerica, Massachusetts.
Fundamentals
| Revenue (TTM) | $138.90M |
| Gross Profit (TTM) | $64.96M |
| EBITDA | $-71.93M |
| Operating Margin | -48.20% |
| Return on Equity | -34.30% |
| Return on Assets | -13.10% |
| Revenue/Share (TTM) | $3.26 |
| Book Value | $6.33 |
| Price-to-Book | 0.60 |
| Price-to-Sales (TTM) | 1.18 |
| EV/Revenue | 0.699 |
| EV/EBITDA | -1.49 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 24.70% |
| Shares Outstanding | $46.94M |
| Float | $36.83M |
| % Insiders | 6.21% |
| % Institutions | 83.45% |
Analyst Ratings
Consensus ($7.33 target)
3
HoldData last updated: 4/9/2026